172 related articles for article (PubMed ID: 9298878)
1. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus.
Torrado J; Ruiz B; Garay J; Asenjo JL; Tovar JA; Cosme A; Correa P
Am J Surg Pathol; 1997 Sep; 21(9):1023-9. PubMed ID: 9298878
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic differences between esophageal and gastric intestinal metaplasia.
Piazuelo MB; Haque S; Delgado A; Du JX; Rodriguez F; Correa P
Mod Pathol; 2004 Jan; 17(1):62-74. PubMed ID: 14631367
[TBL] [Abstract][Full Text] [Related]
3. Lewis, secretor, and ABO phenotypes, and sulfomucin expression in gastric intestinal metaplasia.
Torrado J; Ruiz B; Garay J; Cosme A; Arenas JI; Bravo JC; Fontham E; Correa P
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):287-9. PubMed ID: 9107434
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
5. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
6. Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope.
Bodger K; Campbell F; Rhodes JM
J Clin Pathol; 2003 Sep; 56(9):703-8. PubMed ID: 12944557
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
8. Risks of substance uses, alcohol flush response, Helicobacter pylori infection and upper digestive tract diseases-An endoscopy cross-sectional study.
Chuang YS; Wu MC; Wang YK; Chen YH; Kuo CH; Wu DC; Wu MT; Wu IC
Kaohsiung J Med Sci; 2019 Jun; 35(6):341-349. PubMed ID: 31001924
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus.
Quddus MR; Henley JD; Sulaiman RA; Palumbo TC; Gnepp DR
Hum Pathol; 1997 Sep; 28(9):1007-9. PubMed ID: 9308723
[TBL] [Abstract][Full Text] [Related]
13. The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach.
Van de Bovenkamp JH; Mahdavi J; Korteland-Van Male AM; Büller HA; Einerhand AW; Borén T; Dekker J
Helicobacter; 2003; 8(5):521-32. PubMed ID: 14535999
[TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.
Clark GW
World J Surg; 2003 Sep; 27(9):994-8. PubMed ID: 14560364
[TBL] [Abstract][Full Text] [Related]
15. [Helicobacter pylori in Barrett esophagus].
Kogan Z; Corti R; Cabane A; Fiorini A; Monastra Varrica L; Fernández Marty P; Vasen W
Acta Gastroenterol Latinoam; 1992; 22(4):215-9. PubMed ID: 1340675
[TBL] [Abstract][Full Text] [Related]
16. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic versus histological diagnosis of Barrett's esophagus: a cross-sectional survey.
Irvanloo G; Fallahi B; Ensani F; Azmi M; Morteza A
Pol J Pathol; 2011 Sep; 62(3):152-6. PubMed ID: 22102072
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer.
Wright TA; Myskow M; Kingsnorth AN
Dis Esophagus; 1997 Jul; 10(3):196-200. PubMed ID: 9280079
[TBL] [Abstract][Full Text] [Related]
19. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma.
Endo T; Tamaki K; Arimura Y; Itoh F; Hinoda Y; Hareyama M; Irimura T; Fujita M; Imai K
J Gastroenterol; 1998 Dec; 33(6):811-5. PubMed ID: 9853552
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
